However, the established FCM with mAb 6C12 specific to Omp25 has an advantage over IFS for counting the frequency of intracellular Brucellae-infected monocytes and might be a potential assay for evaluation of therapeutic efficacy of brucellosis patients in clinical practice. The gene discussed is SYNJ2BP; the disease is brucellosis.